Nektar Therapeutics
NKTR
NKTR
163 hedge funds and large institutions have $1.86B invested in Nektar Therapeutics in 2014 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 49 increasing their positions, 50 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 145 → 163 (+18)
2% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 50
Holders
163
Holding in Top 10
3
Calls
$4.03M
Puts
$2.89M
Top Buyers
| 1 | +$35.6M | |
| 2 | +$17.2M | |
| 3 | +$15.5M | |
| 4 |
DFO
Duquesne Family Office
New York
|
+$10.2M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$7.99M |
Top Sellers
| 1 | -$22M | |
| 2 | -$17.4M | |
| 3 | -$15.7M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$13.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.82M |